NR3C1 and neoplasm: To capture the functional differences between skin peri‐tumor regions and the tumor (which exhibits elevated GR activity) and to model the clinical use of glucocorticoids, NK cells were treated with Dex to activate GR signaling, which abrogated their ability to restrict A375 tumor growth (Figure 8H–J).